Advertisement

Topics

Ultimovacs AS Company Profile

09:10 EST 15th December 2018 | BioPortfolio

Ultimovacs AS ('Ultimovacs') was established by Inven2 in 2011. The company's goal is to develop technology from the Norwegian Radium Hospital for use in cancer treatment and to make the treatment available to patients. The technology is based on the possibility of controlling the immune system to make it recognise and kill cancer cells. Ultimovacs is carrying out three clinical trials intended to document that the company's main product, UV1, can produce a controlled immune response and is safe to use, either alone or in combination with other drugs that also activate the immune system to attack cancer cells. The biggest shareholders in the company are Gjelsten Holding AS, Inven2, Langøya Invest AS, Canica AS, Sundt AS and the Norwegian Radium Hospital Research Foundation. From July 2015, the company will be located in Oslo Cancer Cluster Innovation Park at Montebello.


News Articles [3 Associated News Articles listed on BioPortfolio]

Ultimovacs Acquires Immuneed\'s Immunotherapy Unit

The NOK 50.4mm deal includes a rename of the business unit to Ultimovacs AB

Norway biotech Ultimovacs plans IPO to develop cancer drug

Norway's Ultimovacs plans to raise around 700 million Norwegian crowns ($82 million) in an initial public offering in early 2019 to help fund the development of its immunotherapy cancer drug.

Norway biotech Ultimovacs plans IPO to develop cancer drug https://reut.rs/2RwH1ws 

Norway biotech Ultimovacs plans IPO to develop cancer drug https://reut.rs/2RwH1ws 

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Ultimovacs AS

Ultimovacs AS ('Ultimovacs') was established by Inven2 in 2011. The company's goal is to develop technology from the Norwegian Radium Hospital for use in cancer treatment and to m...

More Information about "Ultimovacs AS" on BioPortfolio

We have published hundreds of Ultimovacs AS news stories on BioPortfolio along with dozens of Ultimovacs AS Clinical Trials and PubMed Articles about Ultimovacs AS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ultimovacs AS Companies in our database. You can also find out about relevant Ultimovacs AS Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record